Inflammation

Items 421-430 of 452

per page
Set Descending Direction
  1. Taspine
    CAS  602-07-3
    AG-CN2-0544
    AG-CN2-0544-M0011 mg
    CHF 95.00
    AG-CN2-0544-M0055 mg
    CHF 380.00
    AG-CN2-0544-M01010 mg
    CHF 600.00
    Taspine
  2. TDO (Anopheles gambiae) (rec.) (His)
    AG-40T-0101
    AG-40T-0101-C05050 µg
    CHF 590.00
  3. Thioglycine
    CAS  758-10-1
    AG-CR1-3530
    AG-CR1-3530-M0011 mg
    CHF 110.00
    AG-CR1-3530-M0055 mg
    CHF 440.00
    Thioglycine
  4. Tim-4 (mouse):Fc (human) (rec.)
    AG-40B-0180
    AG-40B-0180-C05050 µg
    CHF 250.00
    AG-40B-0180-30503 x 50 µg
    CHF 500.00
    Tim-4 (mouse):Fc (human) (rec.)
  5. Tim-4 (mouse):Fc (human) (rec.) (Biotin)
    AG-40B-0180B
    AG-40B-0180B-C01010 µg
    CHF 300.00
    AG-40B-0180B-30103 x 10 µg
    CHF 600.00
    Tim-4 (mouse):Fc (human) (rec.) (Biotin)
  6. TNF-α (human) (multimeric) (rec.)
    AG-40B-0019
    AG-40B-0019-C01010 µg
    CHF 215.00
    AG-40B-0019-30103 x 10 µg
    CHF 430.00
  7. TNF-α (mouse) (multimeric) (rec.)
    AG-40B-0021
    AG-40B-0021-C01010 µg
    CHF 215.00
    AG-40B-0021-30103 x 10 µg
    CHF 430.00
  8. TNF-α, Soluble (human) (rec.)
    AG-40B-0006
    AG-40B-0006-C01010 µg
    CHF 95.00
    AG-40B-0006-C05050 µg
    CHF 215.00
    AG-40B-0006-30503 x 50 µg
    CHF 430.00
    TNF-α, Soluble (human) (rec.)(AG-40B-0074) induces NF-κB dependent genes. Methods: Endothelial cells (HUVEC) are incubated for 1h in the presence of BAY 11-7082 (AG-CR1-0013) and then treated with TNFα (20ng/ml) (red bar) or incub
  9. Tofacitinib
    CAS  477600-75-2
    AG-CR1-3625
    AG-CR1-3625-M0055 mg
    CHF 80.00
    AG-CR1-3625-M02525 mg
    CHF 190.00
    Tofacitinib
  10. Tofacitinib . citrate
    CAS  540737-29-9
    AG-CR1-3732
    AG-CR1-3732-M0055 mg
    CHF 60.00
    AG-CR1-3732-M02525 mg
    CHF 140.00
    AG-CR1-3732-M100100 mg
    CHF 260.00
    Tofacitinib . citrate

Items 421-430 of 452

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.